• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Enanta Pharmaceuticals, Inc. - Common Stock (NQ:ENTA)

    10.87 -1.10 (-9.19%)
    Streaming Delayed Price Updated: 2:48 PM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,004,418
    Open 10.22
    Bid (Size) 10.86 (6)
    Ask (Size) 10.90 (3)
    Prev. Close 11.97
    Today's Range 9.910 - 11.85
    52wk Range 4.090 - 15.34
    Shares Outstanding 21,055,392
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga

    Performance

    YTD
    +94.5%
    +94.5%
    1 Month
    +20.8%
    +20.8%
    3 Month
    +41.2%
    +41.2%
    6 Month
    +104.3%
    +104.3%
    1 Year
    +4.9%
    +4.9%

    More News

    Read More
    Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    4 Analysts Have This To Say About Enanta Pharma
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Wondering what's happening in today's after-hours session?
    Via Chartmill
    Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Let's take a look at the stocks that are in motion in today's session.
    Via Chartmill
    Enanta Pharmaceuticals Stock Rises 58% – Here’s An Important Update
    Via Stocktwits
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Top stock movements in today's session.
    Via Chartmill
    Enanta Pharmaceuticals Reports Positive Topline Results from its Phase 2b Study of Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Curious about the stocks that are showing activity after the closing bell on Friday?
    Via Chartmill
    Enanta Pharmaceuticals to Present Topline Results from its Phase 2b Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) in High-Risk Adults
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Announces the Passing of its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate in September Investor Conferences
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co. “HCW@Home” Series
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire
    Enanta Pharmaceuticals to Participate in Baird’s Biotech Discovery Series
    From Enanta Pharmaceuticals, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Enanta Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Enanta Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Enanta Pharmaceuticals, Inc. - Common Stock trade on?
    Enanta Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Enanta Pharmaceuticals, Inc. - Common Stock is ENTA on the Nasdaq Stock Market
    What is the current price of Enanta Pharmaceuticals, Inc. - Common Stock?
    The current price of Enanta Pharmaceuticals, Inc. - Common Stock is 10.87
    When was Enanta Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Enanta Pharmaceuticals, Inc. - Common Stock was at 10/01/25 02:48 PM ET
    What is the market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Enanta Pharmaceuticals, Inc. - Common Stock is 228.87M
    How many shares of Enanta Pharmaceuticals, Inc. - Common Stock are outstanding?
    Enanta Pharmaceuticals, Inc. - Common Stock has 229M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.